AmyCScheflerMD
Ophthalmology • Houston, TXRetinal Disease, Ocular Oncology
Retina Consultants of Texas
Dr. Schefler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin Street
750
Houston, TX 77030Phone+1 713-524-3434Fax+1 713-524-3220
Education & Training
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteChief Residency, Ophthalmology, 2009 - 2010- University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2004 - 2007
Olive View/UCLA Medical CenterInternship, Internal Medicine, 2003 - 2004
Weill Cornell MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2012 - 2026
FL State Medical License 2007 - 2014- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intravitreal Aflibercept Injection for Radiation Retinopathy Start of enrollment: 2012 Nov 01
- Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
- New Biopsy Technique for Uveal Melanoma Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 172 citationsGlobal Retinoblastoma Presentation and Analysis by National Income LevelIdo Didi Fabian, Elhassan Abdallah, Shehu U. Abdullahi, Rula A. Abdulqader, Sahadatou Adamou Boubacar
JAMA Oncology. 2020-05-01 - 1 citationsIncidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma.Debora H Lee, Richard Donkor, Matthew N Parvus, Mark J Dannenbaum, Amy C Schefler
JAMA Ophthalmology. 2023-12-01 - 70 citationsSupraselective intra-arterial chemotherapy: Evaluation of treatment-related complications in advanced retinoblastomaLejla Vajzovic, Timothy G. Murray, Mohammad Ali Aziz-Sultan, Amy C. Schefler, Stacey Q Wolfe
Clinical Ophthalmology. 2011-02-10
Authored Content
- Randomized Trial of Monthly Versus as-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1 Year OutcomesApril 2020
Press Mentions
Aura Biosciences Presents New Preclinical AU-011 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual MeetingMay 3rd, 2021
Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at the American Academy of Ophthalmology 2019 Annual MeetingFebruary 24th, 2020
Light-Activated Agent Novel Option for Uveal MelanomaJanuary 15th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
